Roche's CEO Thomas Schinecker says the company's portfolio of obesity drugs, and those that counter the side effects of weight loss, will help it stand out in the increasingly competitive market..
Back to Health Page
Roche's CEO Thomas Schinecker says the company's portfolio of obesity drugs, and those that counter the side effects of weight loss, will help it stand out in the increasingly competitive market.
Roche's CEO Thomas Schinecker says the company's portfolio of obesity drugs, and those that counter the side effects of weight loss, will help it stand out in the increasingly competitive market..
Back to Health Page
